Skip to content

DR. SOFIE SIMONS

Active
Private limited companyfounded 2018active for 8 yearsVilstraat 28, 3511 Hasselt, BelgiumKBO/BCE: BE 0700.272.001
Summary

DR. SOFIE SIMONS has been active since 2018 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €99,211 and a net result of €33,900. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 95% of 20,320 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Activity
General medical practice
NACE 86210
2 sites
Size
€101,825total assets 2025
Equity
€99,211
Profit
€33,900
Turnover not published (micro format)
Financial health
98 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Structure
Holdings
1
Accounts 58 days early0 of 3 deeds read
Why 98lowers riskLiquidity: current ratio 44.36, cash €77,787Sector: Human health activities (NACE 86)Equity €99,211 (97.4% of total assets)Size: total assets €101,825Show the evidence

Checked score

Score 2025
98 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 84% of its sector peers (NACE 86, micro)
Financial strength · tick = 2024
Strong
Solvency 100+27
equity 97.4% of total assets
Liquidity 100+25
short-term debt 2.1% · cash 76.4%
Profitability 100=
return on assets 33.3%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,036 companies, NACE 86, micro)
Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025highest value 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026lowest value
Credit of up to €9,000 on 30-day terms is acceptable
Liquidity ample (current ratio 44.36, compared with 1.85 in 2024; short-term debt: 2.1% and cash: 76.4% of total assets), and 2.6% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 82% on solvency, 95% on liquidity, 80% on profitability and 81% on growth.

The bankruptcy probability was computed on 11-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskneutral
lowers risk · Liquidity: current ratio 44.36, cash €77,787
NBB · annual accounts
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Equity €99,211 (97.4% of total assets)
NBB · annual accounts
lowers risk · Size: total assets €101,825
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
lowers risk · Growing equity
Reported equity is higher than in 2023 and did not fall compared with 2024. These amounts do not establish the cause of the change.
NBB · annual accounts 2025
Equity per financial year
19202122232425
2019 to 2025 · latest year €99,211
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 03-06-2026, 58 days ahead of the deadline.
NBB · 7 filings
Deviation from the deadline
2025
58 days early
2024
7 days early
2023
7 days early
2022
7 days early
2021
4 days early
2020
9 days early
2019
3 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 14 days before the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 24 July (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
12-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. Liquidity times 24current ratio 44.36
  3. Annual accounts filedfinancial year 2024 · micro…

Financials · financial year 2025, micro format

Equity
€99,211▲ 51.9%
2024 · €65,311
Total assets
€101,825▼ 24.6%
2024 · €134,963
Net result
€33,900▼ 3.7%
2024 · €35,214
Working capital
€92,927▲ 65.0%
2024 · €56,336
Trend over the years

2021 to 2025, 5 financial years 2019 to 2025, 7 financial years

The operating result falls in 2025; 2025 is 8% below 2024.

What the company sold each financial year and what was left of it. A loss stands below the zero line.

Operating result€44,641 2025 Net result€33,900 2025

Use the arrow keys on the chart for the figures per year.

Sector: the middle half of NACE 86, Human health activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA).

Every figure with its change against the financial year before
favourable unfavourable
Line2019202020212022202320242025
Operating result€110,644-€108,036▼ 2.4%€61,475▼ 43.1%€68,111▲ 10.8%€26,072▼ 61.7%€48,553▲ 86.2%€44,641▼ 8.1%
Net result€83,751-€84,210within the sector's middle half▲ 0.5%€48,017within the sector's middle half▼ 43.0%€53,936within the sector's middle half▲ 12.3%€17,783below the sector's middle half▼ 67.0%€35,214within the sector's middle half▲ 98.0%€33,900within the sector's middle half▼ 3.7%
Equity€96,151-€180,361within the sector's middle half▲ 87.6%€234,578within the sector's middle half▲ 30.1%€37,314below the sector's middle half▼ 84.1%€55,097within the sector's middle half▲ 47.7%€65,311within the sector's middle half▲ 18.5%€99,211within the sector's middle half▲ 51.9%
Total assets€124,107-€249,744within the sector's middle half▲ 101%€278,710within the sector's middle half▲ 11.6%€113,428below the sector's middle half▼ 59.3%€106,148below the sector's middle half▼ 6.4%€134,963within the sector's middle half▲ 27.1%€101,825below the sector's middle half▼ 24.6%
Debt€27,956-€69,383▲ 148%€44,131▼ 36.4%€76,115▲ 72.5%€51,051▼ 32.9%€69,651▲ 36.4%€2,614▼ 96.2%
Working capital€95,178-€188,361within the sector's middle half▲ 97.9%€215,616within the sector's middle half▲ 14.5%€13,353below the sector's middle half▼ 93.8%€34,341within the sector's middle half▲ 157%€56,336within the sector's middle half▲ 64.0%€92,927within the sector's middle half▲ 65.0%
Solvency77.5%-72.2%within the sector's middle half▼ 5.3pp84.2%above the sector's middle half▲ 11.9pp32.9%below the sector's middle half▼ 51.3pp51.9%within the sector's middle half▲ 19.0pp48.4%within the sector's middle half▼ 3.5pp97.4%above the sector's middle half▲ 49.0pp
Current ratio4.41-4.47within the sector's middle half▲ 0.069.94above the sector's middle half▲ 5.471.21below the sector's middle half▼ 8.731.73within the sector's middle half▲ 0.531.85within the sector's middle half▲ 0.1144.36above the sector's middle half▲ 42.52
Return on assets (ROA)67.5%-33.7%above the sector's middle half▼ 33.8pp17.2%within the sector's middle half▼ 16.5pp47.6%above the sector's middle half▲ 30.3pp16.8%within the sector's middle half▼ 30.8pp26.1%within the sector's middle half▲ 9.3pp33.3%within the sector's middle half▲ 7.2pp
above within below the middle half of NACE 86, Human health activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30.
Turnover and EBIT margin not published: the micro format does not require them.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €101,825
Fixed assets €6,755 ▼ 43.7%
Current assets €95,070 ▼ 22.7%
Equity and liabilities €101,825
Equity €99,211 ▲ 51.9%
Debt €2,614 ▼ 96.2%
Debt's share of the balance-sheet total falls from 51.6% to 2.6%. Equity is higher and debt is lower.
Key figures and ratios
2025 value · change against 2024
EBITDA
€51,575▼
2024 · €61,532
Cash flow
€40,834▼
2024 · €48,193
Debt to equity
0.03▼
2024 · 1.07
ROE
34.2%▼
2024 · 53.9%
Interest coverage
69.95▲
2024 · 18.89
Debt ≤ 1 year
€2,143▼
2024 · €66,619
Income taxes
€10,004▼
2024 · €10,233
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 26,975 companies that looked in July 2024 the way this one looks now, 1.6% went bankrupt within 24 months and 95% are still going.

  • Micro
  • 5 to 10 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
1.6% went bankrupt
3.4% stopped otherwise
95% still going

A further 0.1% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a lower bankruptcy probability: < 0.1% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,468 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 26,975 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 44 lines
Balance sheet Code20242025
Assets
Total assets20/58€134,963€101,825▼
Fixed assets21/28€12,007€6,755▼
Tangible fixed assets22/27€11,007€5,755▼
Land and buildings22€6,495€5,153▼
Furniture and vehicles24€4,512€602▼
Financial fixed assets28€1,000€1,000=
Current assets29/58€122,956€95,070▼
Amounts receivable within one year40/41€32,684€14,930▼
Trade receivables40€17,456€13,090▼
Other amounts receivable41€15,227€1,840▼
Cash at bank and in hand54/58€89,210€77,787▼
Deferred charges and accrued income490/1€1,062€2,353▲
Equity and liabilities
Total equity and liabilities10/49€134,963€101,825▼
Equity10/15€65,311€99,211▲
Contributions10/11€18,600€18,600=
Reserves13€46,711€80,611▲
Distributable reserves133€46,711€80,611▲
Amounts payable17/49€69,651€2,614▼
Amounts payable within one year42/48€66,619€2,143▼
Current portion of amounts payable after more than one year42€2,235-
Trade debts44€978€115▼
Suppliers440/4€978€115▼
Taxes, remuneration and social security45€3,758€1,879▼
Taxes450/3€3,758€1,879▼
Other amounts payable47/48€59,648€149▼
Accrued charges and deferred income492/3€3,032€471▼
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€12,979€6,934▼
Other operating charges640/8€882€900▲
Gross operating margin9900€62,414€52,476▼
Operating profit (loss)9901€48,553€44,641▼
Financial income75/76B€151-
Recurring financial income75€151-
Financial charges65/66B€3,257€737▼
Recurring financial charges65€3,257€737▼
Profit (loss) for the period before taxes9903€45,447€43,904▼
Income taxes67/77€10,233€10,004▼
Profit (loss) for the period9904€35,214€33,900▼
Profit (loss) for the period to be appropriated9905€35,214€33,900▼
Appropriation of the result
Profit (loss) to be appropriated9906€35,214€33,900▼
Transfer to equity691/2€10,214€33,900▲
To other reserves6921€10,214€33,900▲
Profit to be distributed694/7€25,000-
Return on contributions (dividend)694€23,500-
Directors or managers695€1,500-

The notes to these accounts (6 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line2019202020212022202320242025Change
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630-€32€8,428€11,503€12,857€12,979€6,934▼ 46.6%
Other operating charges640/8--€991€824€1,290€882€900▲ 2.1%
Gross operating margin9900€112,626€108,903€70,893€80,438€40,219€62,414€52,476▼ 15.9%
Operating profit (loss)9901€110,644€108,036€61,475€68,111€26,072€48,553€44,641▼ 8.1%
Financial income75/76B--€21€33-€151--
Recurring financial income75-€30€21€33-€151--
Financial charges65/66B--€344€328€457€3,257€737▼ 77.4%
Recurring financial charges65€114€207€344€328€457€3,257€737▼ 77.4%
Profit (loss) for the period before taxes9903€110,530€107,858€61,151€67,816€25,615€45,447€43,904▼ 3.4%
Income taxes67/77€26,779€23,648€13,134€13,881€7,832€10,233€10,004▼ 2.2%
Profit (loss) for the period9904€83,751€84,210€48,017€53,936€17,783€35,214€33,900▼ 3.7%
Profit (loss) for the period to be appropriated9905€83,751€84,210€48,017€53,936€17,783€35,214€33,900▼ 3.7%
Line2019202020212022202320242025Change
Assets
Total assets20/58€124,107€249,744€278,710€113,428€106,148€134,963€101,825▼ 24.6%
Fixed assets21/28€1,000€7,027€38,965€35,109€24,986€12,007€6,755▼ 43.7%
Tangible fixed assets22/27-€6,027€37,965€34,109€23,986€11,007€5,755▼ 47.7%
Land and buildings22--€2,392€9,234€7,864€6,495€5,153▼ 20.7%
Furniture and vehicles24--€35,573€24,875€16,122€4,512€602▼ 86.7%
Financial fixed assets28€1,000€1,000€1,000€1,000€1,000€1,000€1,000=
Current assets29/58€123,107€242,717€239,745€78,319€81,161€122,956€95,070▼ 22.7%
Amounts receivable within one year40/41€18,320€39,724€15,884€22,490€27,195€32,684€14,930▼ 54.3%
Trade receivables40--€11,520€15,483€5,316€17,456€13,090▼ 25.0%
Other amounts receivable41--€4,363€7,007€21,879€15,227€1,840▼ 87.9%
Cash at bank and in hand54/58€102,584€200,954€222,707€54,279€52,365€89,210€77,787▼ 12.8%
Deferred charges and accrued income490/1--€1,154€1,550€1,601€1,062€2,353▲ 122%
Equity and liabilities
Total equity and liabilities10/49€124,107€249,744€278,710€113,428€106,148€134,963€101,825▼ 24.6%
Equity10/15€96,151€180,361€234,578€37,314€55,097€65,311€99,211▲ 51.9%
Contributions10/11€12,400-€18,600€18,600€18,600€18,600€18,600=
Reserves13€83,751€167,961€215,978€18,714€36,497€46,711€80,611▲ 72.6%
Distributable reserves133--€215,978€18,714€36,497€46,711€80,611▲ 72.6%
Amounts payable17/49€27,956€69,383€44,131€76,115€51,051€69,651€2,614▼ 96.2%
Amounts payable after more than one year17--€19,997€11,143€2,235---
Financial debts170/4--€19,997€11,143€2,235---
Amounts payable within one year42/48€27,929€54,357€24,129€64,966€46,820€66,619€2,143▼ 96.8%
Current portion of amounts payable after more than one year42--€8,801€8,854€8,907€2,235--
Trade debts44€276€3,054€1,318€103€33€978€115▼ 88.2%
Suppliers440/4--€1,318€103€33€978€115▼ 88.2%
Taxes, remuneration and social security45--€14,009€14,009€875€3,758€1,879▼ 50.0%
Taxes450/3--€14,009€14,009€875€3,758€1,879▼ 50.0%
Other amounts payable47/48---€41,999€37,005€59,648€149▼ 99.8%
Accrued charges and deferred income492/3--€6€6€1,995€3,032€471▼ 84.5%
Line2019202020212022202320242025Change
Profit (loss) for the period9904€83,751€84,210€48,017€53,936€17,783€35,214€33,900▼ 3.7%
+ Depreciation and write-downs630-€32€8,428€11,503€12,857€12,979€6,934▼ 46.6%
Operating cash flow (approximation)€83,751€84,241€56,445€65,439€30,640€48,193€40,834▼ 15.3%
Investment in fixed assets (approximation)--€6,058-€40,366-€7,647-€2,734€0-€1,682-
Change in cash-€98,370€21,753-€168,428-€1,914€36,845-€11,423-

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Public contracts: not fully processed yet. The notices from August 2026 to September 2026 are still being read.

Directors

Directors
No directors read yet: 0 of 3 Gazette acts processed. See the directors and other office holders in the KBO →

Owners and capital

Owners

No owners or capital events in the accounts and acts we read.

Group and network

Holdings and subsidiaries

1 holding

Holdings 1

According to the 2025 annual accounts of DR. SOFIE SIMONS and those of the other companies, the acts in the Belgian Official Gazette and the LEI register. Annual accounts state the shareholders that notified the company under article 7:225 of the Code of Companies and Associations and the parent companies that consolidate it. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not include these statements in its annual accounts, or does not have to, is not listed.

Connections & network

No directors read yet: 0 of 3 Gazette acts processed.

History

DR. SOFIE SIMONS was incorporated on 19 July 2018.1 Total assets fell from €124,107 in 2019 to €101,825 in 2025.2

  1. 1KBO (Crossroads Bank for Enterprises)
  2. 2National Bank, annual accounts 2019 and 2025

Acts, filings and financial milestones

Next filing, financial year 2026, expected by 31-07-2027
2026
03-06
NBB filing Annual accounts filed
financial year 2025 · micro format
2025
31-12
Financial Liquidity times 24current ratio 44.36
Current ratio from 1.85 to 44.36; short-term debt falls from €66,619 to €2,143.
24-07
NBB filing Annual accounts filed
financial year 2024 · micro format
2024
24-07
NBB filing Annual accounts filed
financial year 2023 · micro format
2023
31-12
Financial Weakest financial yearnet €17,783 ▼67%
Net result drops to €17,783, the lowest in the series; recovery starts the following year.
24-07
NBB filing Annual accounts filed
financial year 2022 · micro format
2022
27-07
NBB filing Annual accounts filed
financial year 2021 · micro format
2021
31-12
Financial Liquidity more than doubledcurrent ratio 9.94
Current ratio from 4.47 to 9.94; short-term debt falls from €54,357 to €24,129.
31-12
Financial Equity above €200,000equity €234,578 ▲30.1%
A profit in every financial year since 2019 builds equity to €234,578.
22-07
NBB filing Annual accounts filed
financial year 2020 · micro format
2020
31-12
Financial Highest result from 2019 to 2025net €84,210 ▲0.5%
Net result €84,210, the highest in the series.
31-12
Financial Equity above €150,000equity €180,361 ▲87.6%
A profit in every financial year since 2019 builds equity to €180,361.
28-07
NBB filing Annual accounts filed
financial year 2019 · micro format
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 3 deeds read
About the unread acts

We know of 3 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Register details

Identification
Legal formPrivate limited company
Founded19-07-2018
Financial year end31-12
Activities, NACEBEL 2025
86210General medical practice
82100Office administrative and support services
E-invoicing
Reachable via Peppol
Peppol ID 0208:0700272001
Also 9925:BE0700272001
Registered 13-02-2024

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 12 October 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.

Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.

Sites & property

Location & real-estate footprint
Registered office, Hasselt · 2 establishment units since 2018
registered office establishment All 2 establishment units on the map
Ground area
2,792 m²
Building footprint
354 m²
Building volume
1,595 m³
2 parcels, Flanders · tallest building 8.2 m. Linked by address, not a title deed.
2 companies at this address See who is registered here
2 establishment units
DR.SOFIE SIMONS
Arkstraat 42, 3620 LanakenGeneral medical practice
since 2018unit no. 2.277.827.244
DR. SOFIE SIMONS
Vilstraat 28, 3511 HasseltGeneral medical practice
since 2018unit no. 2.277.827.343
2 parcels
Flanders 2 (100%)
Cadastral parcel Region Area Buildings Height / floors
73042D0800/00V000 Flanders 1,821 m² 1 · 245 m² 8.2 m · 1
71032B0617/00D004 Flanders 970 m² 1 · 109 m² 6.1 m · 2
How the parcels are linked
Good to know
Both parcels match the address exactly.